With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly. News headlines Recursion Pharmaceuticals (RXRX) is navigating a challenging ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...